Get the Stockscreener App
0.311
0.29%
0.0009
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Prophase Labs Inc stock is traded at $0.311, with a volume of 331.99K.
It is up +0.29% in the last 24 hours and down -25.69% over the past month.
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
See More
Previous Close:
$0.3101
Open:
$0.3186
24h Volume:
331.99K
Relative Volume:
0.15
Market Cap:
$12.92M
Revenue:
$62.71M
Net Income/Loss:
$-10.48M
P/E Ratio:
-0.4937
EPS:
-0.63
Net Cash Flow:
$-13.77M
1W Performance:
-11.22%
1M Performance:
-25.69%
6M Performance:
+21.48%
1Y Performance:
-87.71%
1-Day Range:
$0.303
$0.32
1-Week Range:
$0.303
$0.3899
52-Week Range:
$0.2179
$3.00
Prophase Labs Inc Stock (PRPH) Company Profile
Name
Prophase Labs Inc
Sector
Industry
Phone
(215) 345-0919
Address
711 STEWART AVE, SUITE 200, NEW YORK, PA
Compare PRPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.311 | 13.55M | 62.71M | -10.48M | -13.77M | -0.63 |
|
TMO
Thermo Fisher Scientific Inc
|
466.03 | 174.85B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
199.27 | 141.13B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
641.37 | 43.07B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
114.85 | 32.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
183.62 | 31.02B | 15.50B | 1.33B | 2.16B | 7.34 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-21 | Initiated | H.C. Wainwright | Buy |
| Oct-13-21 | Downgrade | Dawson James | Buy → Neutral |
| Jan-20-21 | Initiated | Dawson James | Buy |
Prophase Labs Inc Stock (PRPH) Latest News
Sector ETF Data Correlates with Strength in ProPhase Labs Inc.Low Volatility Stable Growth Picks Rank High - metal.it
Is This a Bottoming Phase for ProPhase Labs Inc.Confirmed Setup With Expert Accuracy Supported - beatles.ru
ProPhase Labs Inc. Rebound Backed by Sentiment ShiftInvestment Plan With Growth Optimization Finalized - metal.it
Why is ProPhase Labs Inc. stock attracting strong analyst attentionBreakneck growth rates - Jammu Links News
How does ProPhase Labs Inc. generate profit in a changing economyExceptional trading performance - Jammu Links News
Is ProPhase Labs Inc. a growth stock or a value stockMaximize your portfolio’s earning power - Jammu Links News
What makes ProPhase Labs Inc. stock price move sharplyHigh-yield trading alerts - Jammu Links News
Is ProPhase Labs Inc. a good long term investmentTrack high-yield stocks before they peak - Jammu Links News
What institutional investors are buying ProPhase Labs Inc. stockInvest confidently with data-driven strategies - Jammu Links News
Should I hold or sell ProPhase Labs Inc. stock in 2025Consistently profitable trades - Jammu Links News
How volatile is ProPhase Labs Inc. stock compared to the marketBuild a diversified portfolio for risk management - Jammu Links News
What drives ProPhase Labs Inc. stock priceOver 200% growth - Jammu Links News
What are analysts’ price targets for ProPhase Labs Inc. in the next 12 monthsBuild a winning investment strategy - Jammu Links News
How does ProPhase Labs Inc. compare to its industry peersExceptional earning trajectories - Jammu Links News
What catalysts could drive ProPhase Labs Inc. stock higher in 2025Market Forecast Updates That Work - Jammu Links News
What are ProPhase Labs Inc. company’s key revenue driversAI Powered Forecasts With Proven Results - jammulinksnews.com
ProPhase Labs Announces Shareholder Meeting to Increase Authorized Shares to 1 Billion, Targets $50 Million Covid Accounts Receivables Collection, and Advances BE-Smart Esophageal Cancer Test Development. - AInvest
Screener Results Flag ProPhase Labs Inc. as OversoldSmart Allocation Stock Pick Insights Gaining Interest - metal.it
Why ProPhase Labs Inc. stock attracts strong analyst attentionEntry Alert With Low Drawdown Strategy Noted - beatles.ru
ProPhase Labs Announces Special Meeting of Shareholders and Filing of Preliminary Proxy Statement - GlobeNewswire
ProPhase Labs Inc. Stock Flags Risk Zone in Volatility IndexEarly Entry Picks Before News Breakout Reviewed - metal.it
ProPhase Labs (PRPH) Seeks Shareholder Approval to Expand Share Authorization - GuruFocus
Prophase Labs Files Proxy to Increase Shares - TipRanks
ProPhase Labs Seeks 1 Billion Share Authorization to Transform from Biotech to Crypto Treasury Player - Stock Titan
Will ProPhase Labs Inc. benefit from macro trendsFree Capital Preserving Trade Plan Templates - Newser
Published on: 2025-07-29 09:36:25 - metal.it
Will ProPhase Labs Inc. stock recover after recent dropDeep Learning Stock Forecast for Investors - Newser
Price Consolidation Hints at Upcoming Move in ProPhase Labs Inc.Stock Market Entry Timing Signals Revealed - beatles.ru
Prophase Labs Secures $3M Investment Through Private Placement to Protect Shareholder Value and Fund Operations. - AInvest
What is the dividend policy of ProPhase Labs Inc. stockDiscover high-impact stocks for your portfolio - jammulinksnews.com
Prophase Labs Secures $3M Investment Through Private Placement - TipRanks
What earnings revisions data tells us about ProPhase Labs Inc.Momentum Screener with Buy and Sell Areas - Newser
Published on: 2025-07-28 05:29:42 - Newser
Regression analysis insights on ProPhase Labs Inc. performance Free Buy Alerts With Low Risk Confirmation - Newser
What makes ProPhase Labs Inc. stock price move sharply Daily Stock Forecast Powered by AI Tools - Newser
When is ProPhase Labs Inc. stock expected to show significant growthPowerful profit generation - jammulinksnews.com
What are the technical indicators suggesting about ProPhase Labs Inc.Get daily updates on market movers and shakers - Jammu Links News
Will ProPhase Labs Inc. Stock Benefit from AI and Green Energy TrendsFree Signals Group - Newser
ProPhase Labs Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree AI-Driven Trading Strategies - Newser
Prophase Labs Inc Stock (PRPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.66%
3.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):